Over 300 million people worldwide suffer from major depressive disorder (MDD).
Unfortunately, only 30–40% of patients with MDD achieve complete remission after …

Anti-social behavior and violence are major public health concerns. Globally, violence
contributes to more than 1.6 million deaths each year. Previous studies have reported that …

S-ketamine is approved for treatment-resistant patients with depression and adult patients
with suicide behavior. While ketamine is therapeutically beneficial in adults, there is a dearth …

Sign-tracking is a Pavlovian conditioned approach behavior thought to be important in
understanding cue-driven relapse to drug use, and strategies for reducing sign-tracking may …

Treatment options for chronically aggressive individuals remain limited despite recent
medical advances. Traditional pharmacological agents used to treat aggression, such as …

Ketamine is a dissociative anesthetic that has been shown to have antidepressant effects in
humans and has been proposed as a potential treatment for mood disorders such as …

Traumatic stress, particularly during critical developmental periods such as adolescence,
has been strongly linked to an increased propensity and severity of aggression. Existing …

Traumatic stress has been shown to contribute to persistent behavioral changes, yet the
underlying neural pathways are not fully explored. Structural plasticity, a form of long-lasting …

Résumé Plus des deux tiers des suicides surviennent au cours d'un épisode dépressif
caractérisé. Les mesures de prévention du passage à l'acte et les options thérapeutiques …

Significant social stressors are involved in the development and maintenance of several
neuropsychiatric disorders, many of which also involve alterations in social behavior. The …